AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 105 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,714,000 | -66.6% | 141,194 | -48.7% | 0.01% | -66.7% |
| Q2 2019 | $8,133,000 | +211.5% | 275,226 | +400.7% | 0.03% | +200.0% |
| Q1 2019 | $2,611,000 | +61.8% | 54,963 | +22.9% | 0.01% | +37.5% |
| Q4 2018 | $1,614,000 | -39.4% | 44,711 | +3.3% | 0.01% | -27.3% |
| Q3 2018 | $2,663,000 | +57.3% | 43,262 | +72.6% | 0.01% | +57.1% |
| Q2 2018 | $1,693,000 | +111.4% | 25,068 | +69.7% | 0.01% | +75.0% |
| Q1 2018 | $801,000 | +82.5% | 14,769 | +100.9% | 0.00% | +100.0% |
| Q4 2017 | $439,000 | +46.8% | 7,351 | +19.4% | 0.00% | +100.0% |
| Q3 2017 | $299,000 | +3.1% | 6,156 | +11.7% | 0.00% | 0.0% |
| Q2 2017 | $290,000 | +31.8% | 5,511 | +13.4% | 0.00% | 0.0% |
| Q1 2017 | $220,000 | +56.0% | 4,858 | +30.4% | 0.00% | 0.0% |
| Q4 2016 | $141,000 | 0.0% | 3,726 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $141,000 | +88.0% | 3,726 | -12.3% | 0.00% | – |
| Q2 2016 | $75,000 | +44.2% | 4,248 | 0.0% | 0.00% | – |
| Q1 2016 | $52,000 | -13.3% | 4,248 | +73.5% | 0.00% | – |
| Q4 2015 | $60,000 | +39.5% | 2,448 | 0.0% | 0.00% | – |
| Q3 2015 | $43,000 | 0.0% | 2,448 | 0.0% | 0.00% | – |
| Q2 2015 | $43,000 | -99.6% | 2,448 | -99.3% | 0.00% | -100.0% |
| Q1 2015 | $10,356,000 | +791.2% | 330,451 | +730.3% | 0.04% | +700.0% |
| Q4 2014 | $1,162,000 | +274.8% | 39,800 | +165.3% | 0.01% | +400.0% |
| Q3 2014 | $310,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |